NCT06574152 Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery
| NCT ID | NCT06574152 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Apical Periodontitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-20 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effect of Photobiomodulation (PBM) in postoperative pain after endodontic microsurgery (EMS) in patients from the University of Texas Health Science Center at Houston, School of Dentistry Graduate Endodontic Clinic and to assess the soft tissue healing of the vertical releasing incision (VRI) after PBM
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) I or II. * At least one tooth will receive EMS. * Flap design that includes at least one VRI (triangular, rectangular, papilla base or submarginal rectangular). Exclusion Criteria: * ASA III or IV. * Current heavy smokers (\>10 cigarettes/day) * Uncontrolled diabetes (HbA1c ≥ 7%) or other uncontrolled systemic diseases that may comprise healing, such as vitamin C deficiency, neutrophil deficiencies, immunodeficiency syndromes, or leukemia. * Surgical access on the palatal surface. * Acute swelling or abscess present on the day of the surgery. * Any event or condition that would make continued participation in the study not in the best interest of the subject, as determined by the investigator. * Pregnancy. * Development of any medical condition that might affect the treatment and clinical outcomes, as determined by the investigator. * Initiation of any treatment or exposure that might affect therapy's healing, as determined by the investigator.
Contact & Investigator
Juliana Barros, DDS,MS
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT06574152 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Apical Periodontitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06574152 currently recruiting?
Yes, NCT06574152 is actively recruiting participants. Contact the research team at Juliana.Barros@uth.tmc.edu for enrollment information.
Where is the NCT06574152 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06574152 clinical trial?
NCT06574152 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Juliana Barros, DDS,MS at The University of Texas Health Science Center, Houston. The trial plans to enroll 40 participants.